# Anna Nakayasu

> Anna Nakayasu is a Series A investor at Globis Capital Partners backing Employment. See 3 investments, check sizes, portfolio and contact details. Updated…

- Type: Angel Investor
- Fund: [Globis Capital Partners](https://shizune.co/investors/profile/globis-capital-partners)
- Location: Stanford, United States
- Total investments: 3
- Last investment: Jul 2025
- Lead investor: 33%
- Last updated: Oct 2026
- LinkedIn: https://www.linkedin.com/in/anna-nakayasu
- X (Twitter): https://twitter.com/_dr_anna_

Anna Nakayasu is a Principal at Sozo Ventures. She attended Stanford University Graduate School of Business and The University of Tokyo.

## Contacts

5 contacts available for Anna Nakayasu: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/anna-nakayasu?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Employment | 1 | 33% |
| Recruiting | 1 | 33% |
| Biotechnology | 1 | 33% |
| Career Planning | 1 | 33% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 33% |
| Series C | 1 | 33% |
| Funding Round | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Logomix | Logomix Inc is a mammalian cellular genome architect startup. Logomix proprietary platform, Geno-Writing™, technology integrates large-scale (Mb) human genome-writing technologies and providing genetically architected versatile human cells and/or downsized cells and microbes for drug development and cell & gene therapy area.Majority ofthe cell engineering companies are currently focused on optimization of gene clusters by automatic high throughput system however, Logomix’s Geno-Writing™ provides the required tools for dealing with mammalian or complex genomes. Logomix works with partners by providing new biology-based solutions to co-create business and social values on Geno-Writing™ platform Current Focus Area includes: 1. Human Health & Therapeutics 2. Biomaterials & Chemicals 3. Agriculture & EnvironmentLogomix has 11 ongoing collaborative research partnerships. Currently Logomix is specifically looking for industry partners to address unmet needs in neurodegenerative disease areas. | $18.8M |  | Jul 30, 2025 | https://logomixgenomics.com/en |
| Oceanic Constellations, Inc | Oceanic Constellations empowers ocean visualization with a network of autonomous surface drones and advanced marine monitoring technology. | $8.3M | Series A | Jul 03, 2025 | https://www.oceanic-constellations.com |
| YOUTRUST | YOUTRUST is a startup to operate YOUTRUST a referral recruitment platform for side-job change. |  | Series C | May 13, 2024 | https://youtrust.co.jp/ |

3 of 3 investments shown.

## Co-investors
- [ITOCHU Technology Ventures](https://shizune.co/investors/profile/itochu-technology-ventures) — VC Fund, 2 deals together
- [Angel Bridge](https://shizune.co/investors/profile/angel-bridge) — VC Fund, 1 deal together
- [ANRI](https://shizune.co/investors/profile/anri) — VC Fund, 1 deal together
- [Coral Capital](https://shizune.co/investors/profile/coral-capital) — VC Fund, 1 deal together
- [Delight Ventures](https://shizune.co/investors/profile/delight-ventures) — VC Fund, 1 deal together
- [Femto Partners](https://shizune.co/investors/profile/femto-growth-capital) — VC Fund, 1 deal together

## About Globis Capital Partners

VC Fund · Tokyo, Japan

Globis Capital Partners (GCP) is a venture capital firm in Japan. With its combination of local business presence through Globis Group and the experience of Western VC experience, GCP has set new VC standards in Japan, with hands-on, and in-depth industry expertise.

5 contacts available at Globis Capital Partners.

| Name | Title | Profile |
| --- | --- | --- |
| Minoru Imano | Patner | https://shizune.co/investors/profile/minoru-imano |
| Akihiro Higashi | Principal | https://shizune.co/investors/profile/akihiro-higashi |
| Akihiro Ideguchi | Investment Team | https://shizune.co/investors/profile/akihiro-ideguchi |
| Emre Yuasa | Principal | https://shizune.co/investors/profile/emre-yuasa |
| Jo Konno | Managing Partner | https://shizune.co/investors/profile/mr-jo-konno |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Anna Nakayasu invest in?

Anna Nakayasu invests primarily in Employment, Recruiting and Biotechnology startups, most often at Series A and Series C stage. Most of the 3 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Anna Nakayasu?

Public channels for Anna Nakayasu include LinkedIn and X (Twitter). For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Anna Nakayasu last invest?

The most recent investment recorded for Anna Nakayasu closed in Jul 2025. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co